Stay updated on Pembrolizumab Reirradiation in Glioblastoma Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab Reirradiation in Glioblastoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab Reirradiation in Glioblastoma Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    The footer revision number changes from v3.7.1 to v3.7.2 on the 403 error page.
    Difference
    0.2%
    Check dated 2026-10-18T02:00:33.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    The footer’s ClinicalTrials.gov revision label changed from v3.7.0 to v3.7.1; the page still displays a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-11T02:37:21.000Z thumbnail image
  3. Check
    19 days ago
    No Change Detected
  4. Check
    33 days ago
    Change Detected
    Summary
    The page now shows a 403 Forbidden error, replacing the study record content with an access-denied message. This indicates the study page is temporarily inaccessible.
    Difference
    22%
    Check dated 2026-09-20T01:33:21.000Z thumbnail image
  5. Check
    54 days ago
    Change Detected
    Summary
    The revision stamp on the page updated from v3.6.5 to v3.6.6, indicating a newer release. This appears to be a metadata/versioning update rather than a content change affecting the study details.
    Difference
    0.0%
    Check dated 2026-08-29T20:10:04.000Z thumbnail image
  6. Check
    75 days ago
    Change Detected
    Summary
    Page revision updated from v3.6.4 to v3.6.5, indicating a minor maintenance update to the page. This change does not modify study data, eligibility criteria, or other substantive content.
    Difference
    0.0%
    Check dated 2026-08-08T19:48:49.000Z thumbnail image
  7. Check
    89 days ago
    Change Detected
    Summary
    The revision line on the page updated from v3.6.3 to v3.6.4. This represents a minor update to the page's version information.
    Difference
    0.0%
    Check dated 2026-07-25T12:32:06.000Z thumbnail image

Stay in the know with updates to Pembrolizumab Reirradiation in Glioblastoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Reirradiation in Glioblastoma Clinical Trial page.